J Neurol Surg B Skull Base 2012; 73(04): 273-280
DOI: 10.1055/s-0032-1312710
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Determining Benchmarks in Hearing Preservation Surgery for Vestibular Schwannoma

Michael B. Gluth
1   Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
,
John D. Day
2   Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
,
John L. Dornhoffer
1   Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
› Author Affiliations
Further Information

Publication History

01 August 2011

12 December 2011

Publication Date:
17 May 2012 (online)

Abstract

Objectives The objectives of this study were to determine minimal benchmarks of success in vestibular schwannoma hearing preservation surgery, wherein the likelihood of having preserved hearing in a single patient is at least as likely as having created a poor facial nerve outcome for a single patient.

Design This is a statistical analysis of published literature.

Setting Academic Tertiary Medical Center.

Main Outcome Measures Based on published natural history data, the number needed to treat (NNT) equation was used to calculate the minimally acceptable hearing preservation rates within various hearing classification schemes.

Results Given good facial nerve outcome rates of 85, 90, and 95%, the corresponding hearing preservation rates at 4.7 years that are likely to preserve classes A and B hearing (American Academy of Otolaryngology-Head and Neck Surgery classification) in a single patient as to cause a poor facial nerve outcome are 70, 65, and 60%, respectively. If surgery is limited exclusively to intracanalicular tumors, these rates drop to 62, 57, and 52%, respectively. If the word recognition scoring classification is used, required hearing preservation rates are higher.

Conclusion It is possible to use the NNT equation alongside projected facial nerve outcomes to estimate benchmarks of minimally acceptable hearing preservation rates.

 
  • References

  • 1 Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310 (6977) 452-454
  • 2 Tschudi DC, Linder TE, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol 2000; 21 (5) 722-728
  • 3 Raut VV, Walsh RM, Bath AP , et al. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci 2004; 29 (5) 505-514
  • 4 Woodson EA, Dempewolf RD, Gubbels SP , et al. Long-term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol 2010; 31 (7) 1144-1152
  • 5 Arriaga MA, Chen DA. Facial function in hearing preservation acoustic neuroma surgery. Arch Otolaryngol Head Neck Surg 2001; 127 (5) 543-546
  • 6 Arts HA, Telian SA, El-Kashlan H, Thompson BG. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach. Otol Neurotol 2006; 27 (2) 234-241
  • 7 Harsha WJ, Backous DD. Counseling patients on surgical options for treating acoustic neuroma. Otolaryngol Clin North Am 2005; 38 (4) 643-652
  • 8 Stangerup SE, Thomsen J, Tos M, Cayé-Thomasen P. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol 2010; 31 (2) 271-275
  • 9 Caye-Thomasen P, Dethloff T, Hansen S, Stangerup SE, Thomsen J. Hearing in patients with intracanalicular vestibular schwannomas. Audiol Neurootol 2007; 12 (1) 1-12
  • 10 American Academy of Otolaryngology-Head & Neck Surgery. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995; 113 (3) 179-180
  • 11 Meyer TA, Canty PA, Wilkinson EP, Hansen MR, Rubinstein JT, Gantz BJ. Small acoustic neuromas: surgical outcomes versus observation or radiation. Otol Neurotol 2006; 27 (3) 380-392
  • 12 Arriaga MA, Chen DA, Fukushima T. Individualizing hearing preservation in acoustic neuroma surgery. Laryngoscope 1997; 107 (8) 1043-1047
  • 13 Brackmann DE, Owens RM, Friedman RA , et al. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000; 21 (3) 417-424
  • 14 Colletti V, Fiorino F. Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol 2003; 24 (6) 927-934
  • 15 Dornhoffer JL, Helms J, Hoehmann DH. Hearing preservation in acoustic tumor surgery: results and prognostic factors. Laryngoscope 1995; 105 (2) 184-187
  • 16 Gjurić M, Wigand ME, Wolf SR. Enlarged middle fossa vestibular schwannoma surgery: experience with 735 cases. Otol Neurotol 2001; 22 (2) 223-230 , discussion 230–231
  • 17 Hilton CW, Haines SJ, Agrawal A, Levine SC. Late failure rate of hearing preservation after middle fossa approach for resection of vestibular schwannoma. Otol Neurotol 2011; 32 (1) 132-135
  • 18 Kanzaki J, Inoue Y, Ogawa K. The learning curve in post-operative hearing results in vestibular schwannoma surgery. Auris Nasus Larynx 2001; 28 (3) 209-213
  • 19 Kumon Y, Sakaki S, Kohno K , et al. Selection of surgical approaches for small acoustic neurinomas. Surg Neurol 2000; 53 (1) 52-59 , discussion 59–60
  • 20 Phillips DJ, Kobylarz EJ, De Peralta ET, Stieg PE, Selesnick SH. Predictive factors of hearing preservation after surgical resection of small vestibular schwannomas. Otol Neurotol 2010; 31 (9) 1463-1468
  • 21 Sanna M, Khrais T, Russo A, Piccirillo E, Augurio A. Hearing preservation surgery in vestibular schwannoma: the hidden truth. Ann Otol Rhinol Laryngol 2004; 113 (2) 156-163
  • 22 Satar B, Jackler RK, Oghalai J, Pitts LH, Yates PD. Risk-benefit analysis of using the middle fossa approach for acoustic neuromas with >10 mm cerebellopontine angle component. Laryngoscope 2002; 112 (8 Pt 1) 1500-1506
  • 23 Staecker H, Nadol Jr JB, Ojeman R, Ronner S, McKenna MJ. Hearing preservation in acoustic neuroma surgery: middle fossa versus retrosigmoid approach. Am J Otol 2000; 21 (3) 399-404
  • 24 Colletti V, Fiorino F. Is the middle fossa approach the treatment of choice for intracanalicular vestibular schwannoma?. Otolaryngol Head Neck Surg 2005; 132 (3) 459-466
  • 25 Sameshima T, Fukushima T, McElveen Jr JT, Friedman AH. Critical assessment of operative approaches for hearing preservation in small acoustic neuroma surgery: retrosigmoid vs middle fossa approach. Neurosurgery 2010; 67 (3) 640-644 , discussion 644–645
  • 26 Friedman RA, Kesser B, Brackmann DE, Fisher LM, Slattery WH, Hitselberger WE. Long-term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg 2003; 129 (6) 660-665
  • 27 Niranjan A, Mathieu D, Flickinger JC, Kondziolka D, Lunsford LD. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery. Neurosurgery 2008; 63 (6) 1054-1062 , discussion 1062–1063
  • 28 Pollock BE, Driscoll CL, Foote RL , et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006; 59 (1) 77-85 , discussion 77–85
  • 29 Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 2005; 115 (3) 450-454
  • 30 Suryanarayanan R, Ramsden RT, Saeed SR , et al. Vestibular schwannoma: role of conservative management. J Laryngol Otol 2010; 124 (3) 251-257
  • 31 Walsh RM, Bath AP, Bance ML, Keller A, Rutka JA. Consequences to hearing during the conservative management of vestibular schwannomas. Laryngoscope 2000; 110 (2 Pt 1) 250-255
  • 32 Sughrue ME, Yang I, Aranda D , et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg 2010; 112 (1) 163-167